glp-1/gip agonists Receptor and Diabetic Retinopathy: What ODs Should Know TrimRX | GLP-1 vs GIP:

Action of glucagon-like peptide-1 (GLP-1) in humans.

The glucagon-like peptide 1 receptor agonist exendin-4 improves reference memory performance and decreases immobility in the forced swim test

The glucagon-like peptide 1 receptor agonist liraglutide attenuates placental ischemia-induced hypertension

Purpose-built for physicians Glucose-lowering therapies may reduce risk for dementia, but more research needed Key takeaways: Two research teams found that GLP-1 receptor agonists reduced dementia risk, but results differed regarding SGLT2 inhibitors

doi: 10.1111/jnc.13731 72 NassarNNAl-ShorbagyMYArabHHAbdallahDM

however, in exceptional circumstances, a substance or method may be added to the Prohibited List at any time